Clinical Trial Update: Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study assessing the ocular tolerability of SYL1001 in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• SYL1001

Snippet

Sponsor: Sylentis, S.A. | Conditions: Ocular Pain, Dry Eye | Phase 1 | Status: COMPLETED